Cite

HARVARD Citation

    Alakhras, N. et al. (2018). FcγRIIIa-dependent IFN-γ release in whole blood assay is predictive of therapeutic IgG1 antibodies safety. MAbs. 10 (6), pp. 913-921. [Online]. 
  
Back to record